Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3732792)

Published in Leuk Lymphoma on August 28, 2011

Authors

José A Rodríguez1, Rosendo Luria-Pérez, Héctor E López-Valdés, David Casero, Tracy R Daniels, Shabnum Patel, David Avila, Richard Leuchter, Sokuntheavy So, Elizabeth Ortiz-Sánchez, Benjamin Bonavida, Otoniel Martínez-Maza, Andrew C Charles, Matteo Pellegrini, Gustavo Helguera, Manuel L Penichet

Author Affiliations

1: Molecular Biology Institute, David Geff en School of Medicine, University of California, Los Angeles, CA 90095-1782, USA.

Articles cited by this

Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80

Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res (2008) 6.15

The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol (2006) 3.08

Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Methods Enzymol (2008) 2.61

The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol (2006) 2.18

The transferrin receptor: role in health and disease. Int J Biochem Cell Biol (1999) 2.02

Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J Biol Chem (1999) 1.80

A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc Natl Acad Sci U S A (2005) 1.65

Intraperitoneal antineoplastic drug delivery: rationale and results. Lancet Oncol (2003) 1.45

Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta (2008) 1.44

The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: The mechanisms involved in inhibiting cell-cycle progression. Blood (2001) 1.39

Sorting and recycling of cell surface receptors and endocytosed ligands: the asialoglycoprotein and transferrin receptors. J Cell Biochem (1983) 1.37

Evolution of the iron-responsive element. RNA (2007) 1.27

SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death. J Mol Cell Cardiol (2005) 1.25

Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res (1990) 1.24

An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells. Proc Natl Acad Sci U S A (2002) 1.19

A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients. Blood (2003) 1.17

Genetic regulation of cell function in response to iron overload or chelation. Biochim Biophys Acta (2003) 1.15

Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res (1995) 1.14

Mitochondrial transport in processes of cortical neurons is independent of intracellular calcium. Am J Physiol Cell Physiol (2006) 1.11

Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53. Mol Pharmacol (2009) 1.05

Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor. Blood (2006) 1.05

The small-molecule iron transport inhibitor ferristatin/NSC306711 promotes degradation of the transferrin receptor. Chem Biol (2008) 1.01

Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells. Mol Cancer Ther (2007) 1.00

Binding specificity and internalization properties of an antibody-avidin fusion protein targeting the human transferrin receptor. J Control Release (2007) 0.99

Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species. Leukemia (2008) 0.96

Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells. Leukemia (2010) 0.92

Distinct signaling pathways after higher or lower doses of radiation in three closely related human lymphoblast cell lines. Int J Radiat Oncol Biol Phys (2010) 0.91

Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody. Leukemia (2007) 0.90

The evolution and impact of therapy in multiple myeloma. Med Oncol (2010) 0.90

Long-term engraftment of fresh human myeloma cells in SCID mice. Blood (1992) 0.89

Receptor-mediated endocytosis of human transferrin and its cell surface receptor. J Cell Physiol (1985) 0.88

Dynamics of the cytosolic chelatable iron pool of K562 cells. FEBS Lett (1996) 0.87

Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies. Cancer Res (1986) 0.86

Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis. Int J Oncol (2010) 0.83

Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas. Cancer Res (2010) 0.83

Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Hematol Pathol (1990) 0.83

Articles by these authors

Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature (2008) 26.78

Genome-wide high-resolution mapping and functional analysis of DNA methylation in arabidopsis. Cell (2006) 15.24

Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature (2010) 8.84

Conservation and divergence of methylation patterning in plants and animals. Proc Natl Acad Sci U S A (2010) 7.30

Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell (2008) 5.40

Relationship between nucleosome positioning and DNA methylation. Nature (2010) 5.27

BS Seeker: precise mapping for bisulfite sequencing. BMC Bioinformatics (2010) 4.66

Whole-genome analysis of histone H3 lysine 27 trimethylation in Arabidopsis. PLoS Biol (2007) 4.30

Prolinks: a database of protein functional linkages derived from coevolution. Genome Biol (2004) 4.07

Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem (2002) 3.99

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81

The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol (2006) 3.08

Genome-wide analysis of mono-, di- and trimethylation of histone H3 lysine 4 in Arabidopsis thaliana. Genome Biol (2009) 2.86

Genome-wide association of histone H3 lysine nine methylation with CHG DNA methylation in Arabidopsis thaliana. PLoS One (2008) 2.69

X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc Natl Acad Sci U S A (2008) 2.53

The ontogeny of cKIT+ human primordial germ cells proves to be a resource for human germ line reprogramming, imprint erasure and in vitro differentiation. Nat Cell Biol (2012) 2.41

Epigenetic reprogramming by adenovirus e1a. Science (2008) 2.38

The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol (2006) 2.18

Inference of protein function and protein linkages in Mycobacterium tuberculosis based on prokaryotic genome organization: a combined computational approach. Genome Biol (2003) 2.04

Three acyltransferases and nitrogen-responsive regulator are implicated in nitrogen starvation-induced triacylglycerol accumulation in Chlamydomonas. J Biol Chem (2012) 2.03

Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis. Clin Cancer Res (2003) 2.01

MORC family ATPases required for heterochromatin condensation and gene silencing. Science (2012) 1.97

Distinct vascular conduction with cortical spreading depression. J Neurophysiol (2007) 1.89

Genome resequencing reveals multiscale geographic structure and extensive linkage disequilibrium in the forest tree Populus trichocarpa. New Phytol (2012) 1.88

ATXR5 and ATXR6 are H3K27 monomethyltransferases required for chromatin structure and gene silencing. Nat Struct Mol Biol (2009) 1.85

RNA-seq analysis of sulfur-deprived Chlamydomonas cells reveals aspects of acclimation critical for cell survival. Plant Cell (2010) 1.83

Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell (2010) 1.81

Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer (2010) 1.75

Evolution, genomic analysis, and reconstruction of isobutanol tolerance in Escherichia coli. Mol Syst Biol (2010) 1.75

Systems biology approach in Chlamydomonas reveals connections between copper nutrition and multiple metabolic steps. Plant Cell (2011) 1.74

Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. J Clin Oncol (2004) 1.73

Casein kinase iδ mutations in familial migraine and advanced sleep phase. Sci Transl Med (2013) 1.65

DNA methylation dynamics, metabolic fluxes, gene splicing, and alternative phenotypes in honey bees. Proc Natl Acad Sci U S A (2012) 1.65

Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention. Oncogene (2005) 1.64

BS-Seeker2: a versatile aligning pipeline for bisulfite sequencing data. BMC Genomics (2013) 1.64

The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta (2011) 1.64

Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol (2011) 1.62

Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding. Immunity (2007) 1.60

The histone deacetylase inhibitor LBH589 enhances the anti-myeloma effects of chemotherapy in vitro and in vivo. Leuk Res (2010) 1.59

Reduced threshold for cortical spreading depression in female mice. Ann Neurol (2007) 1.58

Unraveling inflammatory responses using systems genetics and gene-environment interactions in macrophages. Cell (2012) 1.57

Peptide motifs of the single dominantly expressed class I molecule explain the striking MHC-determined response to Rous sarcoma virus in chickens. Proc Natl Acad Sci U S A (2006) 1.55

Evolution of an expanded sex-determining locus in Volvox. Science (2010) 1.55

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS (2015) 1.53

A comparative analysis of DNA methylation across human embryonic stem cell lines. Genome Biol (2011) 1.52

A large-scale zebrafish gene knockout resource for the genome-wide study of gene function. Genome Res (2013) 1.48

Plants regenerated from tissue culture contain stable epigenome changes in rice. Elife (2013) 1.48

Lung cancer incidence and survival among HIV-infected and uninfected women and men. AIDS (2015) 1.47

Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Cancer Res (2004) 1.46

The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol (2009) 1.46

Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res (2009) 1.45

Genomewide clonal analysis of lethal mutations in the Drosophila melanogaster eye: comparison of the X chromosome and autosomes. Genetics (2007) 1.44

Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma. Leuk Lymphoma (2014) 1.44

Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation. Retrovirology (2015) 1.43

Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium. Cell (2012) 1.43

A conserved trimerization motif controls the topology of short coiled coils. Proc Natl Acad Sci U S A (2005) 1.43

Hybrid mouse diversity panel: a panel of inbred mouse strains suitable for analysis of complex genetic traits. Mamm Genome (2012) 1.43

Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS (2011) 1.42

Copy number variation influences gene expression and metabolic traits in mice. Hum Mol Genet (2009) 1.42

Modelling the network of cell cycle transcription factors in the yeast Saccharomyces cerevisiae. BMC Bioinformatics (2006) 1.41

Novel stem/progenitor cell population from murine tracheal submucosal gland ducts with multipotent regenerative potential. Stem Cells (2011) 1.41

Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells. Cell Stem Cell (2013) 1.40

Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma. Tumour Biol (2006) 1.40

Transcriptome sequencing identifies SPL7-regulated copper acquisition genes FRO4/FRO5 and the copper dependence of iron homeostasis in Arabidopsis. Plant Cell (2012) 1.40

Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. J Exp Clin Cancer Res (2014) 1.39

Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy. Cancer Res (2007) 1.39

Transcriptome and methylome interactions in rice hybrids. Proc Natl Acad Sci U S A (2012) 1.39

Systems and trans-system level analysis identifies conserved iron deficiency responses in the plant lineage. Plant Cell (2012) 1.38

Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol (2005) 1.37

Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res (2009) 1.37

Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J Immunol (2004) 1.35

Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis. Cancer Res (2005) 1.35

Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency. Nat Cell Biol (2013) 1.33

Inferring protein interactions from phylogenetic distance matrices. Bioinformatics (2003) 1.32

An improved method for identifying functionally linked proteins using phylogenetic profiles. BMC Bioinformatics (2007) 1.32

Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. J Interferon Cytokine Res (2005) 1.32

Visualization and interpretation of protein networks in Mycobacterium tuberculosis based on hierarchical clustering of genome-wide functional linkage maps. Nucleic Acids Res (2003) 1.31

Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance. Oncogene (2004) 1.30

Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter -592 C/C genotype. Clin Immunol (2003) 1.30

Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways. Genome Biol (2006) 1.29

A revised mineral nutrient supplement increases biomass and growth rate in Chlamydomonas reinhardtii. Plant J (2011) 1.29

Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol Immunol (2006) 1.28

Systems-level analysis of nitrogen starvation-induced modifications of carbon metabolism in a Chlamydomonas reinhardtii starchless mutant. Plant Cell (2013) 1.27

Propulsion of African trypanosomes is driven by bihelical waves with alternating chirality separated by kinks. Proc Natl Acad Sci U S A (2009) 1.26

Determining DNA methylation profiles using sequencing. Methods Mol Biol (2011) 1.26